Ivy Health & Lifesciences Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ivy Health & Lifesciences Pvt. Ltd. - overview
Established
2007
Location
Mohali, Punjab, India
Primary Industry
Healthcare
About
Ivy Health & Lifesciences Pvt. Ltd. is an India-based healthcare provider specializing in advanced medical treatments and comprehensive patient care through a wide array of surgical and diagnostic services. Founded in 2007, Ivy Health & Lifesciences Pvt.
Ltd. is headquartered in Mohali, India, offering specialized healthcare services. The company has undergone significant growth and recently secured a SECONDARY BUYOUT in September 2023, where India Resurgence Fund acquired a majority stake for INR 5250 million from DEG. The current CEO is Praveen Gupta, while the founder is Kanwaldeep Kaur.
Ivy Hospital specializes in providing comprehensive healthcare solutions, focusing on advanced medical treatments and patient care. Their core offerings include a wide range of surgical procedures, diagnostic services, and specialized medical treatments. Designed to address critical health issues, these services cater to patients with various conditions, from chronic illnesses to urgent medical needs. Ivy Hospital serves a diverse client base, including individual patients, families, and referring physicians, with an emphasis on delivering high-quality, tailored healthcare services.
The company operates in multiple geographical markets, strategically targeting regions that exhibit a high demand for specialized medical services, ensuring accessibility to their advanced healthcare solutions. In the most recent year, 2023, Ivy Hospital reported a revenue of INR 46,505,264. 30 and an EBITDA of INR 11,881,619. 10.
The hospital's revenue model is based on direct patient transactions, including pay-for-service arrangements, ensuring straightforward billing processes while also engaging in contracts with insurance companies to facilitate patient access to care. With the recent funding from India Resurgence Fund, Ivy Health & Lifesciences Pvt. Ltd. aims to enhance its infrastructure and expand its footprint in Punjab.
The company is focused on introducing new healthcare products, although specific products and their launch dates have not been disclosed. The funding will support these initiatives by enabling better service delivery and accessibility in targeted regions.
Current Investors
Primary Industry
Healthcare
Sub Industries
Consulting Services, Emergency Services, Hospitals
Website
www.ivyhospital.com
Total Amount Raised
Subscriber access only
Ivy Health & Lifesciences Pvt. Ltd. - timeline of key events
Ivy Health & Lifesciences Pvt. Ltd. - financials
| Fiscal Year Ended | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 919,931,281 | 1,183,471,238 | 1,428,000,185 | 1,780,061,402 | 2,027,625,823 | 2,311,352,973 | 1,949,795,885 | 2,511,680,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | 28.6% | 20.7% | 24.7% | 13.9% | 14.0% | (15.6%) | 28.8% | - | - | - |
| EBITDA (USD) | 184,055,227 | 232,311,329 | 232,421,055 | 184,608,015.6 | 246,844,826 | 347,058,272 | 276,750,365 | 202,623,150 | 627,610,000 | - | - | - |
| Operating Income (USD) | 150,072,129 | 195,470,300 | 160,230,063 | 91,279,796 | 127,709,208 | 202,292,396 | 93,278,984 | 40,314,751 | 423,990,000 | - | - | - |
| Operating Margin | - | 21.2% | 13.5% | 6.4% | 7.2% | 10.0% | 4.0% | 2.1% | 16.9% | - | - | - |
| % EBITDA Margin | - | 25.3% | 19.6% | 12.9% | 13.9% | 17.1% | 12.0% | 10.4% | 25.0% | - | - | - |
| NET Income (USD) | 26,877,530 | 24,189,516 | (72,272,554) | (101,040,063) | (42,822,587) | 23,091,253 | (380,607,029) | (117,002,529) | 61,490,000 | - | - | - |
| % Net Margin | - | 2.6% | (6.1%) | (7.1%) | (2.4%) | 1.1% | (16.5%) | (6.0%) | 2.4% | - | - | - |
Ivy Health & Lifesciences Pvt. Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Ivy Health & Lifesciences Pvt. Ltd. | - | ||||||||
| LP Direct | Completed | Ivy Health & Lifesciences Pvt. Ltd. | - |
Displaying 1 - 2 of 2
Ivy Health & Lifesciences Pvt. Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.